Safety and Efficacy of Fibrin Sealant During Soft Tissue Surgeries

What we are studying

This study is designed to assess the safety and efficacy of fibrin sealant (FS) Grifols in patients undergoing elective (non-emergency) soft tissue open surgery where bleeding may be present.

Who we are studying

  • Men and Women
  • Races:
    • White
    • African American
    • Asian
    • American Indian or Alaska Native
    • Native Hawaiian or Pacific Islander
    • Other
  • All Ethnicities
  • Ages 18+

Eligibility Criteria

  • Undergoing an urologic elective surgery

What is involved

  • 11 visits including a screening and baseline visit prior to surger
  • Surgery
  • 8 post-op visits
  • Physical exams
  • Blood tests
  • Receiving FS Grifols or Surgicel during surgery

Compensation

Patient will receive travel stipend compensation of $40.00 for completing Post-Op Day 7 visit, Post-Op Day 14 visit, Post-Op Week 6 visit, Post-Op Month 3 visit. and Post-Op Month 6 visit. The total amount of travel stipend compensation for the patient will be $200.00 if they complete the entire research study.

Contact Information

Study Coordinator
Abbie Eaton
Email
abeaton@wakehealth.edu
Phone
336-716-9134

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.